ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

AKTX Akari Therapeutics PLC

1.90
0.265 (16.21%)
22 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Akari Therapeutics PLC AKTX NASDAQ Certificado de Depósito
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.265 16.21% 1.90 17:43:07
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
1.58 1.58 2.04 1.91 1.635
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
16/5/202407:05EDGAR2Form 8-K - Current report
15/5/202415:47EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/5/202416:05EDGAR2Form 8-K - Current report
15/3/202411:53PRNUSKuehn Law Encourages VIVK, MINM, SDPI, and AKTX Investors to..
11/3/202416:25EDGAR2Form 425 - Prospectuses and communications, business..
11/3/202416:24EDGAR2Form 8-K - Current report
05/3/202415:57EDGAR2Form 425 - Prospectuses and communications, business..
05/3/202407:34EDGAR2Form 425 - Prospectuses and communications, business..
05/3/202407:28EDGAR2Form 8-K - Current report
09/1/202416:25EDGAR2Form D - Notice of Exempt Offering of Securities
04/1/202411:34EDGAR2Form SC 13D/A - General statement of acquisition of..
02/1/202418:56EDGAR2Form 3 - Initial statement of beneficial ownership of..
02/1/202418:49EDGAR2Form 3 - Initial statement of beneficial ownership of..
02/1/202417:58EDGAR2Form 3 - Initial statement of beneficial ownership of..
02/1/202417:41EDGAR2Form 3 - Initial statement of beneficial ownership of..
02/1/202415:30EDGAR2Form 8-K - Current report
01/12/202307:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/11/202307:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27/10/202315:15EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
20/10/202316:00EDGAR2Form SC 13D/A - General statement of acquisition of..
20/10/202315:29EDGAR2Form POS AM - Post-Effective amendments for registration..
20/10/202315:28EDGAR2Form POS AM - Post-Effective amendments for registration..
20/10/202315:23EDGAR2Form F-3 - Registration statement by foreign private issuers
12/10/202315:43EDGAR2Form S-8 - Securities to be offered to employees in employee..
29/9/202307:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/9/202307:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/9/202308:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
18/8/202307:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/8/202307:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
02/8/202307:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27/7/202307:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
25/7/202307:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
19/7/202307:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/7/202307:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/7/202307:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/7/202315:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/7/202307:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/7/202307:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/6/202315:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..